[Frontiers in Bioscience E4, 669-676, January 1, 2012]

Modes of exocytosis and electrogenesis underlying canine biphasic insulin secretion

Stanley Misler1, Kevin D. Gillis2

1Departments of Medicine and Cell Biology/Physiology, Washington University School of Medicine, St. Louis MO 63110, 2Dalton Cardiovascular Research Center and Department of Biological Engineering, University of Missouri-Columbia, Columbia MO 65211

TABLE OF CONTENTS

1. Abstract
2. Introduction
3. Overview of two distinct modes of exocytosis in canine b-cells
3.1. FPIS, action potentials and phasic exocytosis vs. SPIS, plateau depolarizations and tonic exocytosis.
3.2. Phasic secretion is from an IRP whereas tonic secretion is from a HCSP
4. Summary and perspective
5. Acknowledgments
6. References

1. ABSTRACT

Biphasic insulin secretion in response to glucose consists of a transient first phase followed by a progressive second phase. It is a well described feature of whole perfused pancreases as well as isolated pancreatic islets of Langerhans. Applying to single cell assays of exocytosis (capacitance monitoring and amperometry) to single canine Beta-cells we have examined the time courses of granule exocytosis in response to voltage-clamp depolarizations that mimic two modes of glucose-induced electrical activity, and then compared these to biphasic insulin secretion. Action potentials evoked in short trains at frequencies similar those recorded during first phase insulin secretion trigger phasic exocytosis from a small pool of insulin granules that are likely docked near voltage-activated Ca2+ channels. In contrast, prolonged voltage-clamp pulses mimicking plateau depolarizations occur during second phase insulin secretion and trigger tonic or continuous exocytosis. Comparing the latter results with ones obtained using photorelease of caged Ca2+ in other insulin-secreting cells, we suggest that tonic exocytosis likely results from granule release from a highly Ca2+-sensitive pool of insulin granules, likely located further from Ca2+ channels. Both phasic and tonic modes of exocytosis are enhanced by glucose, via its metabolism. Hence, in canine Beta-cells we propose that two distinct modes of exocytosis, tuned to two types of electrical activity, may underlay biphasic insulin secretion.

2. INTRODUCTION

Beta-cells of the pancreatic islets of Langerhans are endocrine secretory cells that release insulin in a complex, Ca2+ entry-dependent manner in response to glucose. Transport of glucose and other fuel metabolites into the cell, followed by aerobic metabolism of these fuels, drives the conversion of ADP to ATP, which closes ATP sensitive K+, or K+ (ATP), channels. Against a background of open non-selective cation channels, closure of K+ (ATP) channels depolarizes the Beta-cell, opens voltage-dependent Ca2+ channels and triggers localized Ca2+ entry and Ca2+ - dependent exocytosis of insulin granules. As in the case of other excitable endocrine cells, the clustering of Ca2+ entry and Ca2+- dependent K+ channels can give rise to repeated brief bursts of electrical and exocytotic activity (e.g., 1). However, insulin secretion in Beta-cells also has complex kinetics occurring over time scales of several to many minutes. During a sustained rise in plasma glucose concentration occurring over 20-30 minutes, pancreatic islets of Langerhans often display a biphasic insulin secretion consisting of an initial, several minutes-long spike, or first phase, insulin secretion (FPIS). This is followed by a slowly developing but highly persistent dome, or second phase, insulin secretion (SPIS) (2-3). FPIS likely saturates insulin receptors on hepatocytes thereby (i) blocking release of stored or newly formed glucose and (ii) stimulating importation of glucose newly absorbed from the intestinal tract. SPIS provides the sustained circulating concentrations of insulin needed to stimulate glucose uptake by resting myocytes and peripheral adipocytes. In obese individuals, defects in biphasic secretion, coupled with target cell insulin insensitivity, contribute to the over-stimulation of the Beta-cell with eventual loss of secretory capacity (4).

Based largely on work with rodent islets, biphasic insulin secretion has long been attributed to the existence of multiple pools of large, ~300 nm diameter, dense core insulin granules in Beta-cells (e.g., 5). In the simplest formulation of the granule pool hypothesis, one pool of granules is docked to the plasma membrane and released first in response to stimulation, whereas a second reserve pool of granules in the cytoplasm is recruited to the plasma membrane for release with prolonged stimulation (6). Ongoing work, however, suggests that granules may exist in a wide range of functional states that differ in their relationship to the plasma membrane and to Ca2+ channels, and vary in fusion competence and Ca2+ sensitivity (7-18). A current challenge is to map these functional states defined from powerful reductionist approaches to physiologically relevant phases of insulin release elicited by glucose in the native islets.

The present consensus is that an immediately releasable pool (IRP) of vesicles, likely docked nearby high voltage activated Ca2+ channels, is responsible for FPIS (5, 7-8). Release from this pool is triggered by an initial barrage of glucose-evoked action potentials (APs) that produce a local rise in cytosolic (Ca2+) to tens of M, adequate for rapid release utilizing a mechanism with a low affinity for (Ca2+). However, the mechanism of release responsible for SPIS, remains the subject of intense inquiry.

(i) Does the transition from FPIS to SPIS involve physical translocation of "newcomer" granules from a cytoplasmic reserve pool to a readily releasable pool docked to the plasma membrane, as first suggested in 1968 (9)? Phrased in terms of modern cell biology, does the granule pool underlying SPIS consist of granules whose contents are undergoing progressive processing and aggregation while in transit from the Golgi to the plasma membrane? Do members of this granule pool finally attach to the plasma membrane via the formation of protein-protein and protein-lipid complexes involving SNARE proteins and other proteins such as synaptotagmins (e.g., 19), as proposed for granules from other endocrine cells (20, 21)? The approach, docking and fusion of fluorescently labeled granules can now be monitored using total internal reflectance fluorescence microscopy which allows selective imaging of the plasma membrane and submembrane cytoplasm (13, 22-25).

(ii) Do the granule pools underlying FPIS and SPIS, whether already docked, or arriving at the membrane as "newcomers", represent granules in fundamentally different states, in that their fusion is triggered by different Ca2+ levels and/or requires additional stimulants? Proposed candidates for these additional stimulants include slowly developing glucose-derived signal (s) such as the generation cAMP; long chain acyl CoA molelcules; or nitric oxide, all operating independently of closure of K+ (ATP) channels. Alternate, possibilities include enhancement of the pyruvate-malate shuttle and/or actin remodeling to facilitate handoff of newly synthesized granules to docking sites (10, 11, 14). Yet another candidate is Ca2+ entry through an alternate high voltage activated Ca2+ channel (Cav2.3 or R-type) (12). Lastly, it has also been suggested that granules underlying SPIS may have distinct SNARE protein binding affinities (13) or a higher Ca2+ sensitivity than those underlying FPIS, hence responding to a distinct spatio-temporal profile of cytosolic (Ca2+) (15-18).

One possibility that has not received much attention is that underlying the two phases of insulin secretion may be two phases of electrical activity. An examination of our data from canine islets prompted us to consider this possibility and its relationship to two pools of granules with differing Ca2+ sensitivities (26). Single canine Beta-cells display bursts of APs during the interval of glucose stimulated FPIS. On transition to SPIS, Beta-cells display plateau depolarizations to between -30 and -20 mV with few superposed APs (compare Figure 1A and B). To understand how these distinct patterns of electrical activity relate to insulin granule exocytosis from single cells, we measured depolarization-evoked increases in plasma membrane capacitance (Cm) that are proportional to increases in plasma membrane surface induced by granule membrane insertion (27,28). In some experiments we measured simultaneously quantal release events (QREs), where released serotonin, preloaded into insulin granules, is oxidized on the surface of a carbon fiber electrode positioned at the cell surface to produce spikes of amperometric current (29-30). We propose that single APs, or those clustered in brief trains, provoke individual short pulses of Ca2+ entry. These raise restricted domains of submembrane cytosolic (Ca2+) as high as 10s of M and trigger phasic exocytosis (steps of Cm in synchrony with single QREs) from a small, easily exhaustible pool of insulin granules, likely an IRP docked near voltage activated Ca2+ channels. In contrast, we propose that plateau depolarizations resembling those seen during SPIS, provoke slower and lower-amplitude rises in (Ca2+)i. These smaller more global increases in cytosolic calcium trigger slower-to-start tonic exocytosis consisting of steady creeps in Cm and bursts of QREs, which outlast the actual depolarization, and likely occur from a highly Ca2+-sensitive pool (HCSP) of granules located further from Ca2+ channels. The size of the HCSP is enhanced by glucose, as well as by activation of protein kinases A and C (16, 17).

It is worth noting that the joint contribution of both phasic and tonic exocytosis to quantal release during sustained activity is a well appreciated phenomenon in excitable cells. At the neuromuscular junction, increased asynchronous quantal release, recorded as miniature endplate potential activity in muscle, follows a train of endplate potentials synchronized with motor nerve action potentials (31, 32). Also, both phasic and tonic modes of exocytosis, measured as increases in Cm have previously been reported from peptidergic neurophypohyseal terminals and adrenal chromaffin cells (33-35). Hence, by analogy we are proposing that two distinct components of exocytosis, tuned to two components of electrical activity contribute significantly to biphasic insulin secretion in dog, with the added aspect that each component is amplified by the time-dependent effects of glucose metabolism on granule refilling. In addition, we suggest that a similar scheme may underlie at least a component of SPIS in human, pig, and rat Beta-cells, which have recently been shown to have plateau depolarizations and prolonged Ca2+ elevations (1, 18, 36).

3. OVERVIEW OF TWO DISTINCT MODES OF EXOCYTOSIS IN CANINE Beta-CELLS

3.1. FPIS, action potentials and phasic exocytosis vs. SPIS, plateau depolarizations and tonic exocytosis.

Here we present data suggesting that action potentials evoke phasic exocytosis and FPIS while plateau depolarizations evoke tonic exocytosis and SPIS (26).

Figure 1A shows that under conditions of near physiological ambient temperature and bath added forskolin, an activator of adenylyl cyclase, canine islets, dispersed largely to single cells, display biphasic glucose-induced insulin release. FPIS begins at 2-4 min after raising glucose from 3 to 12 mM, peaks at 7 -10 min, and then the declines to a plateau. SPIS emerges from the plateau by 20 min. Fig 1B shows under identical bath conditions biphasic electrical activity has a similar time course as biphasic insulin secretion. By 1-2 min after a similar rise in glucose the Beta-cell depolarizes from its resting potential of nearly -60 mV to trigger isolated APs that subsequently increase in frequency; by 5-7 min after elevating the glucose concentration a bursting mode peaking at ~5 APs/burst and ~4 bursts/min is evident. Thereafter the action potentials, which initially overshoot 0 mV, become smaller and aborted to give way to a plateau depolarization at -30 to -20 mV. This plateau depolarization is temporally correlated with the transition from FPIS to SPIS and continues for minutes into the SPIS.

Secretion and electrical activity are also pharmacologically related. The Na+ channel blocker tetrodotoxin, which reduces AP frequency as well as amplitude, suppresses FPIS leaving a slow creep to SPIS; the Ca2+ channel agonist BAY K8644, which increases plateau depolarization by 5-7 mV, increases SPIS by 3-4 fold (26).

Fig 1C shows that the two patterns of electrical activity clearly evoke two components of exocytosis from voltage-clamped canine Beta-cells. In some cells, voltage clamp depolarizations that simulate individual or short bursts of APs often evoke a fast-on and fast-off phasic component of exocytosis, consisting of single QREs and small (3-5 fF) steps of membrane capacitance (left panel). The defining characteristic of this phasic exocytosis is that it is well-synchronized with the stimulus, terminating within ~50 ms of the AP stimulus. Based on these observations we propose that moderate-frequency AP activity, leading to a phasic component of exocytosis, underlies FPIS.

In contrast, in cells lacking phasic release, it is clear that cell depolarization to -25 mV evokes a tonic component of exocytosis, consisting of barrages of QREs contributing to a large increase in Cm seen at the end of the depolarization (Figure 1C, right panel). Here, however, exocytosis begins up to hundreds of ms after the start of a depolarization, and continues for up to several seconds after its conclusion. In cells where global cytosolic (Ca2+) was measured with a Ca2+ sensing dye, the onset of exocytosis correlated with persistent increases in global cytosolic Ca2+ to >500 nM. We propose that tonic exocytosis induced by plateau depolarizations underlies SPIS. Many cells demonstrate a combination of both phasic and tonic exocytosis.

Both phasic and tonic components of exocytosis elicited by voltage-clamp depolarization are enhanced 2-3 fold at a concentration of ambient glucose that provokes insulin secretion. This should help maintain or enhance exocytosis even in the face of slowly declining AP and plateau depolarization amplitudes.

3.2. Phasic secretion is proposed to be from an IRP whereas tonic secretion is proposed to be from a HCSP

Comparing these results with the finding of distinct pools of granules identified in response to flash photolysis of caged Ca2+ compounds added to the cytoplasm of native or clonal Beta-cells (16, 17), we suggest that it is likely that the granule pools underlying the phasic versus tonic components of exocytosis differ in their Ca2+ sensitivities for fusion, and their localization with respect to plasma membrane Ca2+ channels (see Figure 1D).

We propose that phasic exocytosis evoked by single or short trains of single APs occurs from an IRP closely co-localized with high-voltage-activated Ca2+ channels. This co-localization allows IRP granules to experience micro-domains of cytosolic (Ca2+) in the tens of M during or immediately after APs; these micro-domains are sufficient to trigger exocytosis by a low-affinity Ca2+ sensor. In contrast, we propose that tonic exocytosis evoked by prolonged plateau depolarizations results from HCSP granules that are poorly co-localized with Ca2+ channels. During plateau depolarizations Ca2+ influx is smaller but more prolonged than in the case of APs, therefore HCSP granules experience much smaller (low M) but prolonged rises in cytosolic (Ca2+). Nevertheless, these modest elevations in cytosolic (Ca2+) are sufficient to trigger release because HCSP granules display higher Ca2+ sensitivity than those of the IRP.

Two caveats merit mention here. First, the size of the HCSP may be artificially elevated under our experimental conditions because the HCSP is enhanced by protein kinase A as well as by increasing ambient (glucose) (17), in that our experiments were performed with continuous application of forskolin and often elevated bath (glucose). Second, the HCSP may also make a small contribution to FPIS because trains of action potentials could result in the diffusive spread of the Ca2+ signal to granules of the HCSP (e.g. 15).

Whether both granule pools are docked to the plasma membrane and ready for release in resting cells is unclear. In voltage-clamp experiments at least 100 ms of continuous depolarization to voltages positive to -30 mV is needed to activate tonic release (26). Potentially, this is enough time for granules to translocate to the plasma membrane or to undergo other maturation steps in preparation for release. Moreover, in canine Beta-cells a "priming" depolarization to -35 mV, which allows Ca2+ entry but is not sufficient to promote release, shortens the latency to release in response to subsequent depolarization to membrane voltages positive to -30 mV. Thus modest elevations of intracellular (Ca2+) may mobilize granules into a release-ready state. This is consistent with the observation from caged Ca2+ experiments that the HCSP requires priming with moderate elevations in intracellular Ca2+ in the range of 300-400 nM to be prominent upon photo-elevation of intracellular Ca2+ into the M range (17). In addition, both modes of exocytosis appear to rapidly "run down" during trains of depolarizations suggesting that recruitment of granules is necessary to replenish and maintain both pools of granules during and after intense secretion. In preliminaryexperiments it appears that both phasic and tonic exocytosis recover from depletion over ~ 2 min, apparently along exponential time courses that are accelerated by elevated glucose.

While we have not applied flash photolysis of caged Ca2+ to define the size of the IRP and HCSP in canine Beta-cells, using an indirect method of paired pulse stimulation (37) we tentatively estimate the maximum size of the IRP from the depression of the Cm steps seen in response to the first two 100 or 200 ms depolarizations applied at 1 Hz as 148 fF. This corresponds to ~60 -80 insulin granules of 2-2.5 fF each, and is comparable to the size of the IRP in mouse Beta-cells (17). Estimation of the size of the HCSP from depolarization experiments is more difficult because pool refilling presumably occurs during the depolarizing train. We note that the total Cm, creep recorded during a short train was more than double the IRP.

In comparing multicellular insulin secretion by radioimmunoassay with single-cell electrophysiological assays of exocytosis it is critical to note that the electrophysiological assays only require fusion pore formation and/or the diffusion of a highly mobile small molecule into the extracellular space. Release of the compact, crystalline insulin core may not always occur with every membrane fusion event. In addition, even under conditions where both small and large molecules are successfully released, the kinetics of release of insulin might be significantly slower and its appearance in the bath delayed by up to several seconds. In principle, insulin sensing by amperometry would be an ideal technique for bridging the electrophysiological and immunological assays (38); however in practice, this technique is limited by measurement instability over the many minutes needed to measure biphasic insulin secretion. At present the most promising real-time approach to detecting native granule content release uses total internal reflection fluorescence microscopy to directly visualize granule approach to the plasma membrane and then discharge of its contents, (e.g. GFP-tagged insulin and/or C-peptide fragment or Zn2+) (23-25), whose release is monitored with an extracellular fluorescent chelator. Assays of granule core release, though not critical to our qualitative arguments, might be important for any future quantitative reconciliation of results from the various approaches (38a).

4. SUMMARY AND PERSPECTIVE

We propose that canine Beta-cells may provide a relatively simple model for biphasic insulin secretion. Based on comparison of the time courses of biphasic insulin secretion measured by radioimmunoassay with electrical activity and exocytosis we have proposed a simple model of dual mode of electrical activity plus a dual mode of exocytosis to account for glucose-induced insulin release. Action potentials evoked in short trains at frequencies similar to those recorded during first phase insulin secretion trigger phasic exocytosis from a small pool of insulin granules that are likely docked near voltage activated Ca2+ channels. In contrast, prolonged voltage-clamp depolarizations designed to mimic plateau depolarization occurring during second phase insulin secretion, trigger tonic exocytosis from a highly Ca2+-sensitive pool of insulin granules that are likely located further from Ca2+ channels. The model incorporates both the well-studied relationship of AP activity to exocytosis from the IRP, likely prominent in FPIS of many species, and a novel relationship of plateau depolarization to exocytosis from an HCSP. The scaling of these features by glucose-induced and time-dependent changes in the sizes of IRP and HCSP may counteract subtle time-dependent changes in distinct patterns of electrical activity, such as decreases in AP frequency or sags in plateau depolarization amplitude, and hence maintain and even enhance the distinct secretory phases. This new model is complementary to others of biphasic secretion. While de-emphasizing the potential involvement of distinct Ca2+ channels in the two phases of secretion (12), it emphasizes the importance of docking of different pools of insulin granules, here proposed to be of distinctly different Ca2+ sensitivity and located at varying distance from Ca2+ entry channels. In modified forms this model may also apply to humans (1) and other species, for example, pig (18) and rat (36) where intermittent periods of plateau depolarizations occur with prolonged glucose stimulation.

Comparison of the results from canine Beta-cells with the much more extensive sets of data from mouse Beta-cells suggests that the results are complementary. First the data from canine Beta-cells are consistent with glucose metabolism contributing to SPIS, though the metabolic intermediates or target exocytotic molecules are as yet unknown. Second, as the tonic exocytosis is readily exhaustible with seconds of intermittent depolarization, resupply of fusion-competent granules, either through physical translocation or biochemical maturation, is clearly important to sustain this mode of secretion. Third, though we have not had the opportunity to extensively "phenotype" the HVA Ca2+ channels in the dog Beta-cells, preliminary observations suggest that both L- type and non-L-type channels contribute to SPIS. In particular, high doses of nifedipine fail to completely block the whole cell HVA Ca2+ current, whereas the L-type channel opener BAYK 8644 dramatically increases SPIS. Finally, though mouse Beta-cells display bursting pacemaker activity (36) rather than plateau depolarizations, long bursts at glucose concentrations greater than 10 mM might deplete phasic exocytosis leaving tonic exocytosis evoked by cumulative elevations of global intracellular (Ca2+) that result from the prolonged burst.

This model leaves several key questions unanswered:

1. Where are HCSP granules located? Whereas it is clear that IRP granules are located close to Ca2+ channels, it is not yet clear if HCSP granules are preferentially targeted to sites with a paucity of Ca2+ channels or just simply randomly distributed on the cell surface.

2. What are the molecular determinants that distinguish the Ca2+ sensitivity of HCSP versus IRP granules? For example, do HCSP granules utilize different synaptotagmin isoforms as Ca2+sensors (39, 40, 40a)?

3. Do HCSP and IRP granules have different molecular apparatus to target granules to specific docking sites? For example, are there differences in SNARE adaptor proteins such as MUNCs (41, 42) or different interactions with cytoskeletal elements (43)?

Do granules in the HCSP differ from the IRP in the mode of fusion pore opening and closure and thus differ in the time course and/or quantity of insulin that is released during an exocytotic event (44-46)?

In order to address these questions and test the basic model it will be important to develop and employ molecular tools to selectively manipulate FPIS versus SPIS and/or the IRP versus HCSP granule population. Selective three- to four-fold reduction of SPIS has been engineered by specific "knock-down" of one of two proteins. These are (i) MUNC 18c, a SNARE adaptor protein which interacts with syntaxin 4 in the docking of granules to the plasma membrane (42, 43) and (ii) cdc42, a Rho GTPase, whose glucose-dependent cycling appears critical for the remodeling of filamentous actin and the hand-off of granules to the syntaxin 4/MUNC18c complexes (47). The cdc42 knock-down is especially interesting because it suggests that molecules other than traditional motors, such as myosin Va (48, 49) may modulate granule supply and pool refilling.

In contrast, preferential enhancement of the HCSP compared to the IRP has been observed following expression of SNAP-25 mutations (e.g., S187E) that mimic phosphorylation of the protein by protein kinase C in INS-1 cells (50). Use of these mutations to study glucose-induced insulin secretion may help strengthen the link between the HCSP and SPIS.

Finally, there has also been expanding interest in (i) the molecular determinants controlling fusion pore dynamics, and (ii) the roles of pore dynamics in mediating differential release of peptides versus small molecular weight cargoes (e.g., catecholamines) in large, dense core endocrine granules. In the case of the insulin granules, the ultimate size of the fusion pore, as well as the crystalline state of the granule, may determine the relative release of monomeric vs. polymeric insulin, and perhaps the relative release of insulin for endocrine function vs. the release of ATP or GABA for paracrine function (25, 45). Hence, does the relative proportion of insulin to non-insulin secreting exocytotic events differ for phasic/IRP vs. tonic /HCSP pools and does knock-down of MUNC18c or cdc42, or expression of SNAP-25 S187E, change fusion pore properties?

5. ACKNOWLEDGEMENTS

This review is based on published work from the authors labs supported by NIH DK37380, DK20579 (DRTC Washington University St. Louis) to SM; and NIH NS40453 and NS48826 to KDG. We thank Zhuan Zhou, Yan Yang, Amelia Silva, Adam Dickey, David Pressel and David Barnett for their contributions to the development of ideas and performance of the studies.

6. REFERENCES

1. Misler S, Barnett DW, Gillis KD. Update on electrophysiology of stimulus-secretion coupling in human b-cells. In "Retrospective on Perspectives in Diabetes". R.P. Robertson, Alexandria, American Diabetes Association (2006).

2. Curry DL, Bennett LL, Grodsky GM. Dynamics of insulin secretion by the perfused rat pancreas. Endocrinology 83:572-84 (1968).
doi:10.1210/endo-83-3-572
PMid:4877098

3. Felig P, Bergman M. The endocrine pancreas: diabetes mellitus. In Endocrinology and Metabolism 3rd edition. Felig P, Baxter JD, Frohman LA, eds p. 1107-250 (1995).

4. Gerich JE. Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type-2 diabetes? Diabetes 51 Suppl 1:S117-S121 (2002).
doi:10.2337/diabetes.51.2007.S117

5. Oloffson CS, Goepel SO, Barg S, Galvanovski J, Ma X, Salehi A, Rorsman P, Eliasson L. Fast insulin secretion reflects exocytosis of docked granules in mouse pancreatic B-cells. Pfluegers Arch- Eur J Physiol 444:43-51 (2002).

6. Grodsky GM. A threshold distribution hypothesis for package storing of insulin and its mathematical modeling. J Clin Invest 51:2047-59 (1972).
doi:10.1172/JCI107011
PMid:4559946    PMCid:292361

7. Barg S, Ma X, Eliasson L, Galvanovskis J, Gopel SO, Obermuller S, et al. Fast exocytosis with few calcium channels in insulin-secreting mouse pancreatic b-cells. Biophys J 81:3308-23 (2001).
doi:10.1016/S0006-3495 (01)75964-4

8. Barg S, Eliasson L, Renstrom E, Rorsman P. A subset of 50 secretory granules in close contact with L-type Ca2+ channels accounts for first-phase insulin secretion in mouse beta-cells. Diabetes 51:74-82 (2002).
doi:10.2337/diabetes.51.2007.S74

9. Lacy PE, Howell SL, Young DA, Fink CJ. A new hypothesis of insulin secretion. Nature 219:1177-1180 (1968).
doi:10.1038/2191177a0
PMid:4877537

10. Henquin J-C, Ishiyama N, Nenquin M, Ravier MA, Jonas J-C. Signals and pools underlying biphasic insulin secretion. Diabetes 51:60-7 (2002).
doi:10.2337/diabetes.51.2007.S60

11. Gunawardana SC, Rocheleau JV, Head WS, Piston DW. Mechanisms of time-dependent potentiation of insulin release: Involvement of nitric oxide synthase. Diabetes 55:1029-33 (2006).
doi:10.2337/diabetes.55.04.06.db05-1532
PMid:16567525

12. Jing X, Li D-Q, Olofsson C, Salehi A, Surve VV, Caballero J, et al. Cav2.3 calcium channels control second-phase insulin release. J Clin Invest 115:146-54 (2005).
PMid:15630454    PMCid:539196

13. Ohara-Imaizumi M, Fujiwara T, Nakamichi Y, Okamura T, Akimoto Y, Kawai J, et al. Imaging analysis reveals mechanistic difference between first- and second-phase insulin exocytosis. J Cell Biol 177:695-705 (2007).
doi:10.1083/jcb.200608132
PMid:17502420    PMCid:2064214

14. Thurmond DC, Gonelle-Gispert C, Furukawa M, Halban PA, Pessin JE. Glucose stimulated insulin secretion is coupled to the interaction of actin with the t-SNARE (target membrane soluble N-ethylmaleimidesensitive factor attachment protein receptor protein) complex. Mol Endocrinol 17:732-742 (2003).
doi:10.1210/me.2002-0333
PMid:12554769

15. Pedersen MG, Sherman A. Newcomer insulin secretory granules as a highly calcium sensitive pool. Proc Natl Acad Sci USA 106:7432-7436 (2009).
doi:10.1073/pnas.0901202106
PMid:19372374    PMCid:2678592

16. Wan, Q.-F., H. Yang, X. Lou, J. Ding, and T. XuProtein kinase activation increases insulin secretion by sensitizing the secretory machinery to calcium. J Gen Physiol 124:653-662 (2004).
doi:10.1085/jgp.200409082
PMid:15572345    PMCid:2234026

17. Yang Y, Gillis KD. A highly Ca-sensitive pool of granules is regulated by glucose and protein kinases in insulin-secreting INS-1 cells. J Gen Physiol 124:641-51 (2004).
doi:10.1085/jgp.200409081
PMid:15572344    PMCid:2234025

18. Misler S, Silva AM, Dickey AS, Barnett DW. Phasic and tonic modes of depolarization-exocytosis coupling in β-cells of porcine islets of Langerhans. Channels 3:101-9. (2009).
doi:10.4161/chan.3.2.7866
PMid:19242115

19. Gauthier BR, Wollheim CB Synaptotagmins bind calcium to release insulin. Am J Physiol Endocrinol Metab 295: E279-286. (2008).
doi:10.1152/ajpendo.90568.2008
PMid:18713958

20. Michael DJ, Cai H, Xiong W, Ouyang J, Chow RH. Mechanisms of peptide hormone secretion. Trends in Endocrinology and Metabolism 17:408-145 (2006).
doi:10.1016/j.tem.2006.10.011
PMid:15681023

21. Park JJ, Loh YP. How peptide hormone vesicles are transported to the secretion site for exocytosis. Molec Endoc 22 (12):2583-2595 (2008).
doi:10.1210/me.2008-0209
PMid:18669645    PMCid:2626200

22. Oheim M, Loerke D, Chow RH, Stuehmer W. Evanescent wave microscopy: a new tool to gain insight into the control of transmitter release. Phil Trans R Soc Lond B 354:307-318 (1999).
doi:10.1098/rstb.1999.0382
PMid:10212479    PMCid:1692489

23. Qian W-J, Gee KR, Kennedy RT. Imaging of Zn2+ release from pancreatic β-cells at the level of single exocytotic events. Anal Chem 75:3468-3475 (2003).
doi:10.1021/ac0341057
PMid:14570199

24. Rutter GA, Hill EV. Insulin vesicle release: walk, kiss, pause... then run. Physiology 21:189-196 (2006).
doi:10.1152/physiol.00002.2006
PMid:16714477

25. Michael DJ, Ritzel RA, Haataja L, Chow RH. Pancreatic β-cells secrete insulin in fast- and slow release forms. Diabetes 55:600-60. (2006)
doi:10.2337/diabetes.55.03.06.db05-1054
PMid:16505221

26. Misler S, Zhou Z, Dickey AS, Silva AM, Pressel D, Barnett DW. Electrical activity and exocytotic correlates of biphasic insulin secretion from β-cells of canine islets of Langerhans: contribution of tuning two modes of Ca2+-dependent exocytosis to two modes of glucose-induced electrical activity. Channels 3: 181-193. (2009)
doi:10.4161/chan.3.3.8972
PMid:19535907

27. Gillis KD, Misler S. Single cell assays of exocytosis from pancreatic islet B cells. Pfluegers Arch (EurJ Physiol) 420:121-123 (1992).
doi:10.1007/BF00378654

28. Ammala C, Eliasson L, Bokvist K, Larsson O, Ashcroft FM, Rorsman P. Exocytosis elicited by action potentials and calcium currents in individual mouse pancreatic B-cells. J Physiol 472:665-88 (1993).
PMid:8145165    PMCid:1160506

29. Smith PA, Duchen MR, Ashcroft FM. A fluorimetric and amperometric study of calcium and secretion in isolated mouse pancreatic beta-cells. Pfluegers Arch (Eur J Physiol) 430:808-18 (1995).
doi:10.1007/BF00386180

30. Zhou Z, Misler S. Amperometric detection of quantal secretion from patch-clamped rat pancreatic β-cells. J Biol Chem 271:270-277. (1996)
doi:10.1074/jbc.271.1.270
PMid:8550572

31. Liley AW. The effects of presynaptic polarization on the spontaneous activity at the mammalian neuromuscular junction. J Physiol 134:427-43 (1956).
PMid:13398923    PMCid:1359215

32. Ravin, R, Parnas H, Spira ME, Parnas I. Simultaneous measurement of evoked release and (Ca2+)i in a crayfish release bouton reveals high affinity of release to Ca2+ J Neurophysiol 81:634-642 (1999).
PMid:10036266

33. Zhou Z, Misler S. Action potential-induced quantal secretion of catecholamines from rat adrenal chromaffin cells. J Biol Chem; 271:3498-505 (1995).

34. Seward EP, Chernevskaya NI, Nowycky MC. Exocytosis in peptidergic nerve terminals exhibits two Ca-sensitive phases during pulsatile calcium entry. J Neurosci 15:3390-9 (1995)
PMid:7751918

35. Seward EP, Nowycky MC. (1996) Kinetics of stimulus-coupled secretion in dialyzed bovine chromaffin cells in response to trains of depolarizing pulses. J Neurosci 16:553-62 (1996).
PMid:8551339

36. Antunes CM, Salgado AP, Rosario LM, Santos RM. Differential patterns of glucose-induced electrical activity and intracellular calcium responses in single mouse and rat pancreatic islets. Diabetes 49:2028-2038 (2000).
doi:10.2337/diabetes.49.12.2028
PMid:11118004

37. Gillis KD, Mossner R, Neher E. Protein kinase C enhances exocytosis from chromaffin cells by increasing the size of the readily releasable pool of secretory granules. Neuron 16:1209-1220 (1996)
doi:10.1016/S0896-6273 (00)80147-6

38. Huang L, Shen H, Atkinson MA, Kennedy RT Detection of exocytosis from pancreatic beta cells by amperometry at a chemically modified microelectrode. Proc Natl Acad Sci USA 92:9608-9612 (1995)
doi:10.1073/pnas.92.21.9608

38a. Obermüller S, Lindqvist A, Karanauskaite J, Galvanovskis J, Rorsman P, Barg S. Selective nucleotide-release from dense-core granules in insulin-secreting cells. J. Cell Sci. 18:4271-82 (2005).
doi:10.1242/jcs.02549
PMid:16141231

39. Schonn J-S, Maximov A, Lao Y, Sudhof TC, Sorensen JB. Synaptotagmin-1 and -7 are functionally overlapping Ca2+ sensors for exocytosis in adrenal chromaffin cells. Proc Natl Acad Sci USA 105:3998-4003. (2008).
doi:10.1073/pnas.0712373105
PMid:18308932    PMCid:2268838

40. Gustavsson N, Lao Y, Maximox A, Chuang J-C, Kostromina Repa JA, Li C, et al. Impaired insulin secretion and glucose tolerance in synaptotagmin-7 null mutant mice. Proc Natl Acad Sci USA 105:3992-7. (2008).
doi:10.1073/pnas.0711700105
PMid:18308938    PMCid:2268794

41. Oh E, Thurmond DC. The stimulus-induced tyrosine phosphorylation of Munc18c facilitates vesicle exocytosis. J Biol Chem 281:17624-17634. (2006).
doi:10.1074/jbc.M601581200
PMid:16638745    PMCid:2396333

42. Oh E, Thurmond DC. Munc18c depletion selectively impairs the sustained phase of insulin release. Diabetes 58:1165-1174. (2009).
doi:10.2337/db08-1059
PMid:19188424    PMCid:2671048

43. Jewell JL, Luo W, Oh E, Wang Z, Thurmond DC. Filamentous actin regulates insulin exocytosis through direct interaction with syntaxin 4. J Biol Chem 283:10716-10726. (2008).
doi:10.1074/jbc.M709876200
PMid:18285343    PMCid:2376824

44. Jackson MB, Chapman ER. The fusion pores of Ca2+-triggered exocytosis. Nat Struct Mol Biol 15:684-689. (2008).
doi:10.1038/nsmb.1449

45. MacDonald PE, Braun M, Galvanovskis J, Rorsman P. Release of small transmitters through kiss and-run fusion pores in rat pancreatic β- cells. Cell Metabolsim 4:283-290 (2006).
doi:10.1016/j.cmet.2006.08.011
PMid:17011501

46. Kwan EP, Gaisano HY. Glucagon-like peptide 1 regulates sequential and compound exocytosis in pancreatic islet β−cells. Diabetes 54:2734-2743 (2005).
doi:10.2337/diabetes.54.9.2734
PMid:16123364

47. Wang Z, Oh E, Thurmond DC. Glucose-stimulated Cdc42 signaling is essential for the second phase of insulin secretion. J Biol Chem 282:9536-9546. (2007).
doi:10.1074/jbc.M610553200
PMid:17289663    PMCid:2396332

48. Ivarsson R, Jing X, Waselle L, Regazzi R, Renström E. Myosin 5a controls insulin granule recruitment during late-phase secretion. Traffic 6:1027-1035. (2005)
doi:10.1111/j.1600-0854.2005.00342.x
PMid:16190983

49. Varadi A, Tsuboi T, Rutter GA. Myosin Va transports dense core secretory vesicles in pancreatic MIN6 beta-cells. Mol Biol Cell 16:2670-2680. (2005)
doi:10.1091/mbc.E04-11-1001
PMid:15788565    PMCid:1142415

50. Shu Y, Liu X, Yang Y, Takahashi M, Gillis KD Phosphorylation of SNAP-25 at Ser 187 mediates enhancement of exocytosis by a phorbol ester in INS-1 cells. J Neurosci 28: 21-30 (2008) .
doi:10.1523/JNEUROSCI.2352-07.2008
PMid:18171919

Key Words: Biphasic Insulin Secretion; Exocytosis; Granule Pools; Phasic Release; Tonic Release, Review

Send correspondence to: Stanley Misler, Departments of Medicine and Cell Biology/Physiology, Box 8126, Washington University School of Medicine, St. Louis MO 63110, Tel: 314-454-7719, Fax :314-454-5126, E-mail:smisler@dom.wustl.edu